Stockscreener 앱 받기
125.45
1.40%
-1.78
시간 외 거래:
125.45
Gilead Sciences Inc 주식(GILD)의 최신 뉴스
Gilead Sciences (GILD) Seeks FDA Approval for Weekly HIV Prevention Pill - GuruFocus
GILD Receives FDA Acceptance for Yeztugo as HIV Preventative - GuruFocus
Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
FDA accepts Gilead application for once-weekly oral HIV prevention pill - Investing.com Canada
Director sale notice: GILD (NASDAQ: GILD) files Form 144 for 9,000 shares - Stock Titan
U.S. FDA Accepts Gilead’s Application for Investigational Once-Weekly Oral Yeztugo, Potentially the First Long-Acting Pill for HIV Prevention - Yahoo Finance Singapore
Morgan Stanley files Rule 144 for GILD common shares (GILD) - Stock Titan
Regulatory Milestone Boosts Gilead’s Presence in Liver Disease Care - Insider Monkey
Former Gilead COO Asks Judge to Nix `Rape’ in Woman’s Harassment Trial - MyNewsLA.com
Gilead Sciences Patent Application Challenged Over Potential Impact on ARIPO Contracting States - pan african visions
Panagora Asset Management Inc. Sells 321,348 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Public Employees Retirement Association of Colorado Has $111.55 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Resources Management Corp CT ADV Lowers Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Arax Advisory Partners Has $3.60 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Atlas Capital Advisors Inc. Takes $1.01 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat
177,100 Shares in Gilead Sciences, Inc. $GILD Purchased by Adams Diversified Equity Fund Inc. - MarketBeat
Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC - Insider Monkey
Voya Global High Dividend Low Volatility Portfolio's Gilead Sciences Inc(GILD) Holding History - GuruFocus
Victory Capital Management Inc. Sells 109,808 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by State Street Corp - MarketBeat
Gilead (GILD) Supports Faster South Africa Access to Lenacapavir - Insider Monkey
Martingale Asset Management L P Acquires 21,153 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Rhenman & Partners Asset Management AB Buys 46,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Titan Investment Solutions Ltd Invests $6.20 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Trillium Asset Management LLC Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Macquarie Group Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by Banco Santander S.A. - MarketBeat
Castleark Management LLC Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat
4,220,501 Shares in Gilead Sciences, Inc. $GILD Bought by Boston Partners - MarketBeat
Gross profit of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView
Enterprise value of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView
Net income before discontinued operations of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView
Long term debt to total assets ratio of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView
Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh Dividends – BCBA:GILD.CI - TradingView
Long term debt to total equity ratio of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView
GILD Donates Antiviral Therapy to Support Ebola Response in Ugan - GuruFocus
Gilead donates remdesivir to Uganda for Ebola outbreak response - Investing.com
Gilead donates remdesivir to Uganda for Ebola outbreak response By Investing.com - Investing.com Canada
Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response, Building on Decade-Long Commitment to Outbreak Relief - Business Wire
UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Vaughan David Investments LLC IL Invests $33.80 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Xponance LLC Has $29.15 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
FY2026 EPS Forecast for Gilead Sciences Reduced by Analyst - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by Sector Gamma AS - MarketBeat
Swiss National Bank Has $417.34 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Te Ahumairangi Investment Management Ltd Sells 8,180 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Meiji Yasuda America Inc Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
Nuveen LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by Great Lakes Advisors LLC - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by DJE Kapital AG - MarketBeat
Aviva PLC Acquires 59,782 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
ASO GROUP Ltd Acquires New Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Andra AP fonden Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones - Sahm
SF: Rememberance Work Is Future Work: Gilead Commits $3M For Hiv/Aids Education And Preservation - SFGATE
CAR T-Cell Therapy for Non-Hodgkin’s lymphoma Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Gilead Sciences, Kite Pharma, Novartis, BMS, Allogene Therapeut - Barchart.com
Gilead Sciences Inc (GILD) Stock Up 3.6% but GF Value Says Overv - GuruFocus
Gilead (GILD) CMO Dietmar Berger converts RSUs and withholds shares for taxes - Stock Titan
Gilead (GILD) CFO exercises 2,796 RSUs and withholds 1,341 shares for taxes - Stock Titan
Gilead (NASDAQ: GILD) officer reports RSU vesting and tax withholding on Form 4 - Stock Titan
Gilead (GILD) CEO Daniel O'Day exercises RSUs and withholds shares for taxes - Stock Titan
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
National AIDS Memorial and the Gilead Foundation Launch Major Investment to Expand HIV/AIDS Education and Community Leadership - Gilead Sciences
Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now? - Insider Monkey
Gilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD) - MarketBeat
Gilead Sciences Inc Stock (GILD) Moved Up by 3.48% on Jun 11: Key Drivers Unveiled - TradingKey
Scotiabank Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $177 - Moomoo
National AIDS Memorial and the Gilead Foundation Launch Major Investment to Expand HIV/AIDS Education and Community Leadership – Company AnnouncementFT.com - Financial Times
Johnson Wealth Management LLC Makes New $2.51 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by Illinois Municipal Retirement Fund - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by LPL Financial LLC - MarketBeat
Cerity Partners LLC Buys 19,673 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
0.46%
0.23%
자본화:
|
볼륨(24시간):